the edition, showing how the Church reacted to his journalistic investigations, including its reaction when he stated to members that some people describe the organisation as a "cult". At one point during an interview, the presenter lost his temper with the Church's international spokesman; an edited portion of this incident was released subsequently by the Church on YouTube and DVD in an attempt to publicise it and raise controversy. However, the 2007 Scientology episode was Panoramas greatest audience since it moved to Monday evening. A follow-up programme, The Secrets of Scientology, was broadcast on 28 September 2010, presenting proof that the Church had harassed Sweeney during the making of the earlier documentary, with the specific intention of making him react in the way he eventually did. The episode also included numerous interviews with former high-ranking members of the organisation who had been subject to harassment. Panorama and Seroxat Since 2002, Panorama has made four programmes about the anti-depressant Seroxat (paroxetine / Paxil): "The Secrets of Seroxat" (2002); "Seroxat: Emails from the Edge" (2003); "Taken on Trust" (2004) and "Secrets of the Drug Trials" (2007). "The Secrets of Seroxat" elicited a record response from the public as 65,000 people telephoned the BBC helpline and 1,300 people emailed Panorama directly. The major mental health charity Mind collaborated with Panorama in a survey of those who emailed the programme. Anonymous findings from the 239 responses were sent to the Medicines and Healthcare products Regulatory Agency (MHRA). The second Panorama programme on Seroxat, "Emails from the Edge", included a report of the survey to which the 239 people responded. It showed widespread experiences of suicidal feelings and other severe reactions, very bad withdrawal symptoms and lack of warnings from doctors. After the broadcast users/survivors and Mind protested outside the offices of the MHRA. On 29 January 2007, the fourth documentary of the series about the drug Seroxat was broadcast. It focused on three GlaxoSmithKline paediatric clinical trials on depressed children and adolescents. Data from the trials show that Seroxat could not be proven to work for teenagers. Not only that, one clinical trial indicated that they were six times more likely to become suicidal after taking it. In the programme, Panorama revealed the secret trail of internal emails which show how GlaxoSmithKline manipulated the results of the trials for its own commercial gain. Access to the documents has been gained as GlaxoSmithKline fights a